American Pharmaceutical Partners to Report 2003 Third Quarter Financial Results and Host Conference Call on October 23
SCHAUMBURG, Ill., Oct. 15 /PRNewswire-FirstCall/ -- American
Pharmaceutical Partners, Inc. (Nasdaq: APPX) said that on Thursday,
October 23, 2003, the company will release its financial results for its
2003 third quarter. The company also said that Patrick Soon-Shiong, M.D., the
company's Chairman, President and Chief Executive Officer, Nicole Williams,
Chief Financial Officer, Derek Brown, Co-Chief Operating Officer, and Jeffrey
Yordon, Co-Chief Operating Officer, will host an investor conference call that
same day at 8:30 a.m. Pacific (11:30 a.m. Eastern) to review the company's
financial results and operations.
The conference call will be available to interested parties through a live
audio Internet broadcast at www.appdrugs.com and www.fulldisclosure.com . The
call will be archived and accessible at both sites for one year.
About American Pharmaceutical Partners, Inc.
American Pharmaceutical Partners, Inc. is a specialty drug company that
develops, manufactures and markets injectable pharmaceutical products,
focusing on the oncology, anti-infective and critical care markets. APP has
acquired the exclusive North American rights to manufacture and market
ABRAXANE(TM), a proprietary nanoparticle injectable oncology product that has
completed Phase III clinical trials for metastatic breast cancer and for which
the FDA has granted "Fast Track" designation. The NDA submission has
commenced and the submission is now ongoing. The company believes that it has
established the only commercial scale protein-engineered nanoparticle
manufacturing capability in the United States. For more information, visit
APP's website at www.appdrugs.com .
SOURCE American Pharmaceutical Partners, Inc.
Executive Vice President & CFO of American
Pharmaceutical Partners, Inc.
or Robert Jaffe
Whetstone, both of PondelWilkinson MS&L for American Pharmaceutical Partners,
/Web site: http://www.appdrugs.com